Company Filing History:
Years Active: 2004
Title: Ludwig Wildt: Innovator in Pharmaceutical Preparations
Introduction
Ludwig Wildt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for side effects associated with GnRHa therapy. His innovative work has led to the creation of effective pharmaceutical preparations that address various side effects experienced by patients undergoing this therapy.
Latest Patents
Ludwig Wildt holds a patent for pharmaceutical preparations aimed at treating side effects during and/or after GnRHa therapy. This patent includes formulations that contain effective amounts of chemically modified derivatives of 17α-estradiol, 17β-estradiol, and estriol. Notably, the preparations containing 14α, 15α-methylene-1,3,5(10),8-tetraene-3,17α-diol are particularly preferred for their efficacy.
Career Highlights
Wildt is associated with Jenapharm GmbH & Co. KG, where he has been instrumental in advancing pharmaceutical innovations. His work has not only contributed to the company's portfolio but has also positively impacted patient care by providing solutions to common side effects of hormone therapies.
Collaborations
Ludwig Wildt has collaborated with esteemed colleagues, including Mcihael Oettel and Peter Licht. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.
Conclusion
Ludwig Wildt's contributions to pharmaceutical preparations demonstrate his commitment to improving patient outcomes in hormone therapy. His innovative spirit and collaborative efforts continue to drive advancements in the field.